1. Home
  2. BYSI vs ACCL Comparison

BYSI vs ACCL Comparison

Compare BYSI & ACCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BeyondSpring Inc.

BYSI

BeyondSpring Inc.

N/A

Current Price

$0.74

Market Cap

31.4M

Sector

Health Care

ML Signal

N/A

Logo Acco Group Holdings Limited Ordinary Shares

ACCL

Acco Group Holdings Limited Ordinary Shares

SELL

Current Price

$2.61

Market Cap

26.9M

ML Signal

SELL

Company Overview

Basic Information
Metric
BYSI
ACCL
Founded
2010
2009
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
31.4M
26.9M
IPO Year
2016
2024

Fundamental Metrics

Financial Performance
Metric
BYSI
ACCL
Price
$0.74
$2.61
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 80.2K
47.9K
Earning Date
05-13-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$17.13
Revenue Growth
N/A
N/A
52 Week Low
$0.57
$1.23
52 Week High
$2.44
$5.00

Technical Indicators

Market Signals
Indicator
BYSI
ACCL
Relative Strength Index (RSI) 47.65 43.78
Support Level $0.67 $2.42
Resistance Level $0.80 $3.16
Average True Range (ATR) 0.05 0.22
MACD 0.02 -0.05
Stochastic Oscillator 69.43 28.53

Price Performance

Historical Comparison
BYSI
ACCL

About BYSI BeyondSpring Inc.

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment. Its first asset, Plinabulin is a novel brain-penetrant microtubule modulator with dendritic cell maturation and vasculature modulation mechanism, which has the potential to help mitigate acquired resistance from prior immune checkpoint inhibitors (ICI) treatment in cancer patients. It is a Selective Immunomodulating Microtubule-Binding Agent (SIMBA), which may provide multiple therapeutic opportunities.

About ACCL Acco Group Holdings Limited Ordinary Shares

Acco Group Holdings Ltd is a holding company. Through its Operating Subsidiaries, it is a multi-disciplinary, IT-driven corporate service provider with a presence in Hong Kong and Singapore. Under the Accolade brand, it specializes in offering corporate secretarial services and accounting services in Hong Kong, as well as intellectual properties (IP) registration services in Singapore. Leveraging developed IT solutions, It provides comprehensive, reliable and professional support to its clients, enabling them to focus on their core business activities while it manages and handles their corporate compliance needs. Its clientele ranges from individual clients, small and medium-sized enterprises to multinational corporations, reflecting its ability to cater to diverse business needs.

Share on Social Networks: